CC
Therapeutic Areas
IXALTIS Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Litoxetine (IXA-001) | Undisclosed Urogenital Disorder (likely female) | Phase 2 |
| IXA-002 | Undisclosed Genitourinary Disorder | Undisclosed |
| IXA-003 | Undisclosed Genitourinary Disorder | Undisclosed |
| Drug | Indication | Phase |
|---|---|---|
| Litoxetine (IXA-001) | Undisclosed Urogenital Disorder (likely female) | Phase 2 |
| IXA-002 | Undisclosed Genitourinary Disorder | Undisclosed |
| IXA-003 | Undisclosed Genitourinary Disorder | Undisclosed |